Literature DB >> 8805860

Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice.

A Corallini1, D Campioni, C Rossi, A Albini, L Possati, M Rusnati, G Gazzanelli, R Benelli, L Masiello, V Sparacciari, M Presta, F Mannello, G Fontanini, G Barbanti-Brodano.   

Abstract

OBJECTIVE: To characterize the T53 cell line and its clones derived from an adenocarcinoma of BK virus (BKV)/tat transgenic mice and to establish the role of native Tat in tumorigenicity, induction of metastases and angiogenesis. DESIGN AND METHODS: Tat was quantified by flow cytometry and chloramphenicol acetyltransferase (CAT) assays. Tumorigenicity and metastatic ability of cell lines were assayed in nude mice. Production of proteases was evaluated by a plasmin chromogenic assay and gelatinase zymography. The angiogenic effect was studied in vivo with conditioned medium from tumour cell lines.
RESULTS: Tat protein was detected in tumour cell lines in amounts from 600-7000 molecules/cell. Conditioned medium from tumour cell lines was able to transactivate an LTR-CAT in HL3T1 cells, indicating release of extracellular Tat. Tumour cell lines, inoculated into nude mice induced angiogenic tumours with remarkable recruitment of host endothelial cells. Metastases were detected in lymph nodes, lungs, kidneys, and heart. Cell lines produced relevant amounts of proteases. Conditioned medium implanted in mice with matrigel induced an angiogenic response, enhanced by addition of heparin. Preincubation with an anti-Tat antibody abolished the angiogenic effect.
CONCLUSIONS: Tat from cells from BKV/tat transgenic mice promotes tumorigenesis and formation of metastases and induces angiogenic activity. Angiogenesis occurs at physiological concentrations of Tat lower than 20 ng/ml. The effects of Tat on induction of metastases and angiogenesis appear to be mediated by activation of proteases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805860     DOI: 10.1097/00002030-199606001-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

Review 1.  The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Authors:  John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2012-07-09       Impact factor: 9.079

2.  AIDS - Associated Kaposi's Sarcoma: A Double Jeopardy.

Authors:  O Prakash; G H Porter
Journal:  Ochsner J       Date:  1999-04

3.  Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.

Authors:  Pejman Rahimian; Johnny J He
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 2.643

Review 4.  Non-AIDS-defining cancers among HIV-infected patients.

Authors:  James Cutrell; Roger Bedimo
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

5.  Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model.

Authors:  L Possati; D Campioni; F Sola; L Leone; L Ferrante; C Trabanelli; M Ciomei; M Montesi; R Rocchetti; S Talevi; S Bompadre; A Caputo; G Barbanti-Brodano; A Corallini
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

6.  Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers.

Authors:  Julia L Marcus; Chun Chao; Wendy A Leyden; Lanfang Xu; Jeanette Yu; Michael A Horberg; Daniel Klein; William J Towner; Charles P Quesenberry; Donald I Abrams; Michael J Silverberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-24       Impact factor: 4.254

7.  Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.

Authors:  Navneet K Dhillon; Fang Li; Bing Xue; Ossama Tawfik; Susan Morgello; Shilpa Buch; Amy O'Brien Ladner
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-27       Impact factor: 6.914

8.  Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study.

Authors:  Lesley S Park; Janet P Tate; Keith Sigel; Sheldon T Brown; Kristina Crothers; Cynthia Gibert; Matthew Bidwell Goetz; David Rimland; Maria C Rodriguez-Barradas; Roger J Bedimo; Amy C Justice; Robert Dubrow
Journal:  Ann Intern Med       Date:  2018-06-12       Impact factor: 25.391

9.  Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.

Authors:  Ru Feng Wu; Ying Gu; You Cheng Xu; Stefania Mitola; Federico Bussolino; Lance S Terada
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 10.  Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk.

Authors:  Alvaro H Borges; Robert Dubrow; Michael J Silverberg
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.